In this study we performed RNA-sequencing of MCF7 cells expressing single-point phospho-deficient STAT5a mutants treated with PRL in attempts to identify differentially expressed genes and functional pathways for cancer outgrowth. The gene discussed is PRL; the disease is cancer.